Dogness International Corporation announced that its Rechargeable Pet Repellent Mat has consistently been among the top 3 best-sellers in its category on Amazon US since 2025, even reaching the No. 1 daily best-seller spot multiple times in early 2026. The mat uses low-voltage static pulses to gently guide pet behavior, appealing to modern pet owners seeking humane training solutions. Dogness continues to improve the product based on user feedback and plans to expand its product line in behavior management, smart feeding, and health monitoring to support harmonious pet ownership worldwide.
Dogness's Rechargeable Pet Repellent Mat maintains strong consumer interest. For readers following consumer cyclical stocks, here is Pluang's market snapshot as of Oct 29, 2026 19:02 WIB: Of 134 priced US Consumer Cyclical stocks tradable on Pluang, 92 rose and 37 fell today. Notable movers include EBAY at USD 123.88 (+4.97%), ORLY at USD 94.62 (+4.83%), and MBLY at USD 6.73 (-4.67%).
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
